Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
NCT02537054
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Pseudoxanthoma Elasticum
Interventions
DRUG:
Aflibercept
Sponsor
University Hospital, Bonn